Mélanome localement avancé et métastatique : nouveautés [Locally advanced and metastatic melanoma : novelties]

Details

Serval ID
serval:BIB_E5DDB348D97F
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Mélanome localement avancé et métastatique : nouveautés [Locally advanced and metastatic melanoma : novelties]
Journal
Revue medicale suisse
Author(s)
Huber A., Latifyan S., Nikolopoulou A., Homicsko K., Berthod G., Michielin O., Özdemir B.C.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
27/05/2020
Peer-reviewed
Oui
Volume
16
Number
695
Pages
1092-1097
Language
french
Notes
Publication types: Journal Article ; Review
Publication Status: ppublish
Abstract
The standard of care of melanoma patients has evolved at a rapid pace with the advent of immune checkpoint inhibitors and BRAF and MEK inhibitors. ESMO guidelines were revised in September 2019 to integrate the results of recent studies that broaden the indication of these treatments to the adjuvant setting and validated new limitations to completion lymph node dissection in the case of a positive sentinel lymph node biopsy in locally advanced melanoma. We hereby detail the main novelties of the revised ESMO 2019 guidelines.
Keywords
Antineoplastic Agents/therapeutic use, Humans, Lymph Node Excision, Melanoma/therapy, Practice Guidelines as Topic, Sentinel Lymph Node Biopsy, Skin Neoplasms/therapy
Pubmed
Create date
10/06/2020 21:08
Last modification date
23/10/2020 5:26
Usage data